$LGND LIGAND PHARMACEUTICALS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in LIGAND PHARMACEUTICALS INC for free.
IRS Number: 770160744
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: LGND
Company Address: 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO 92121
Phone number: 858-550-7500
Market Capitalization: $2.24B
Prev close: $107.84
Average Daily Volume: 309,645
Days Low: $106.18
Year Low: $82.06
Year High: $139.79
LIGAND PHARMACEUTICALS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 08 2021 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 630 | 0 | 25,061 | 24.4 K to 25.1 K (+2.58 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
| Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 |